51.61
price up icon1.73%   0.88
pre-market  Pre-mercato:  50.81   -0.80   -1.55%
loading

Akero Therapeutics Inc Azioni (AKRO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
5.14%
50.65
53.39 38.63 27.98 21.79
Interest Income/Expense
10.48%
0.991
0.897 0.888 0.857 0.457
Operating Income/Loss
3.10%
-59.95
-61.87 -46.62 -35.63 -28.75
Income/Loss From Continuing Operations Before Tax
3.34%
-53.34
-55.19 -39.66 -31.08 -25.83
Income/Loss From Continuing Operations After Tax
3.34%
-53.34
-55.19 -39.66 -31.08 -25.83
Net Income/Loss
3.34%
-53.34
-55.19 -39.66 -31.08 -25.83
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,488%
59.31
1.0614 55.61 51.87 46.94
Diluted Average Shares
5,488%
59.31
1.0614 55.61 51.87 46.94
Basic Earnings Per Share
11.76%
-0.90
-1.02 -0.71 -0.60 -0.55
Diluted Earnings Per Share
11.76%
-0.90
-1.02 -0.71 -0.60 -0.55
Common Stock Dividends
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$1.16
price up icon 0.87%
$31.13
price down icon 0.19%
$576.61
price down icon 1.37%
$303.77
price down icon 0.76%
$4.5807
price down icon 0.41%
$487.86
price down icon 0.60%
Capitalizzazione:     |  Volume (24 ore):